SCHEMBL22155087

SCHEMBL22155087

O=[N+]([O-])c1ccc(Cl)cc1-c1cc2ccccc2c2ccc3ccccc3c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPRT1 P00492 1/20 0.50
▸ TSHR P16473 3/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ MAPK1 P28482 3/20 0.42
▸ MAPT P10636 2/20 0.42
▸ TDP1 Q9NUW8 1/20 0.41
▸ PDE7A Q13946 6/20 0.40
▸ PDE7B Q9NP56 3/20 0.40
▸ CASP6 P55212 1/20 0.40
▸ HPGD P15428 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ TNF P01375 1/20 0.38
▸ NOD1 Q9Y239 1/20 0.38
▸ HNF4A P41235 1/20 0.38
▸ CDK2 P24941 1/20 0.38
▸ MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22127145 0.86 HPRT1 (0.50) HPRT1TSHRALDH1A1MAPK1MAPT
SCHEMBL24030376 0.81 ALDH1A1 (0.53) HPRT1TSHRALDH1A1MAPK1MAPT
SCHEMBL22155632 0.77 MAPK1 (0.45) HPRT1TSHRALDH1A1MAPK1MAPT
SCHEMBL25561346 0.76 MAPK1 (0.56) TSHRALDH1A1MAPK1MAPTTDP1
SCHEMBL22155094 0.75 MAPT (0.50) HPRT1TSHRALDH1A1MAPK1MAPT
SCHEMBL11516745 0.75 MAPK1 (0.69) TSHRALDH1A1MAPK1MAPTTDP1
SCHEMBL1334963 0.75 HSD17B10 (0.63) HPRT1TSHRALDH1A1MAPK1MAPT
SCHEMBL17063444 0.74 ALDH1A1 (0.54) HPRT1TSHRALDH1A1MAPTTDP1
SCHEMBL19918524 0.73 MEN1 (0.47) TSHRALDH1A1MAPK1MAPTTDP1
SCHEMBL19997903 0.72 MAPK1 (0.45) HPRT1TSHRALDH1A1MAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11296282-B2 Organic compound and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-04-05 — — US disclosed
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-25 — — US disclosed
US-9439896-B2 Quinolines as FGFR kinase modulators ASTEX THERAPEUTICS LTD (GB) 2016-09-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11296282-B2 Organic compound and organic electroluminescence device using the same SLCO4C1, EML4, SLCO2A1 HPRT1 447/4885TSHR 4244/4885ALDH1A1 386/4885
US-20200203632-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME SLCO4C1, EML4, SLCO2A1 HPRT1 447/4885TSHR 4244/4885ALDH1A1 386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback